+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preclinical Imaging Market by Product, Type, Imaging Modality, Applications, End Users - Global Forecast 2026-2032- Product Image
Preclinical Imaging Market by Product, Type, Imaging Modality, Applications, End Users - Global Forecast 2026-2032- Product Image
Sale

Preclinical Imaging Market by Product, Type, Imaging Modality, Applications, End Users - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968721
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Preclinical Imaging Market is projected to reach USD 4.09 Billion in 2026. It is expected to continue growing at a CAGR of 5.96%, reaching USD 5.81 Billion by 2032.

Preclinical imaging is a critical translational research capability that enables noninvasive visualization of anatomy, physiology, metabolism, biodistribution, and treatment response in small-animal disease models. The field spans micro-CT, micro-MRI, PET, SPECT, optical imaging, ultrasound, photoacoustic systems, multimodal platforms, imaging probes, radiotracers, software, and contract imaging services used by pharmaceutical companies, biotechnology firms, academic institutes, CROs, and government laboratories.

Demand is supported by the continued need to improve drug discovery productivity, reduce late-stage clinical attrition, and generate reproducible in vivo evidence before first-in-human studies. As oncology, neuroscience, cardiometabolic disease, inflammation, infectious disease, and gene and cell therapy pipelines become more complex, preclinical molecular imaging is increasingly positioned as an enabling technology for biomarker validation, pharmacokinetics, pharmacodynamics, toxicology, and longitudinal disease monitoring.

Transformative Shifts in the Preclinical Imaging Landscape

The preclinical imaging landscape is shifting from standalone instruments toward integrated, multimodal, and data-rich research ecosystems. PET/CT, SPECT/CT, PET/MRI, optical-CT, ultrasound-photoacoustic, and hybrid imaging workflows are helping researchers connect structural, functional, and molecular readouts in the same animal over time, strengthening translational confidence while supporting 3Rs principles by reducing animal use through longitudinal study designs.

Technology adoption is also being shaped by higher-resolution detectors, improved image reconstruction, targeted probes, theranostic radiotracers, cloud-enabled image management, and standardized quantification workflows. At the same time, laboratories are prioritizing reproducibility, regulatory-grade data integrity, and interoperable software as sponsors and CROs align preclinical evidence packages with increasingly biomarker-driven clinical development strategies.

Cumulative Impact of Artificial Intelligence on Preclinical Imaging

Artificial intelligence is becoming a practical accelerator in preclinical imaging by improving segmentation, image registration, denoising, reconstruction, phenotyping, and quantitative biomarker extraction. AI-enabled workflows can reduce reader variability, accelerate high-throughput analysis, and support longitudinal comparisons across cohorts, which is especially valuable in oncology tumor burden assessment, neuroimaging, fibrosis modeling, and biodistribution studies.

The cumulative impact of AI is strongest when algorithms are validated against curated datasets, transparent quality controls, and standardized acquisition protocols. Industry adoption is therefore moving toward explainable AI, audit-ready analytics, and human-in-the-loop review rather than fully autonomous interpretation, helping research teams improve productivity without compromising scientific rigor or regulatory confidence.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a leading hub for preclinical imaging due to its concentration of pharmaceutical R&D, federally supported biomedical research, venture-backed biotechnology, and specialized CRO capacity. The United States and Canada continue to advance molecular imaging, radiochemistry, oncology, neuroscience, and translational medicine programs through academic medical centers and research-intensive institutions. Europe benefits from strong academic networks, cross-border research collaboration, radiopharmaceutical expertise, and regulatory emphasis on reproducibility, animal welfare, and data integrity, with Germany, France, the United Kingdom, Italy, and Spain supporting broad adoption across drug discovery and disease modeling.

Asia-Pacific is expanding rapidly as China, Japan, South Korea, India, Australia, and ASEAN research centers increase investment in translational medicine, biotechnology, radiotracer development, and advanced imaging infrastructure. Latin America is gaining traction through university hospitals, public research institutes, and growing oncology, infectious disease, and metabolic research activity, with Brazil and Mexico acting as important regional anchors. The Middle East is investing in biomedical innovation through academic medical centers, precision medicine initiatives, and national diversification strategies, while Africa’s opportunity is emerging through infectious disease research, public health partnerships, and gradual expansion of imaging-enabled preclinical capabilities.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, rising biomedical research capacity, expanding clinical research ecosystems, and manufacturing-linked life sciences investment are supporting demand for compact, cost-efficient preclinical imaging solutions and outsourced imaging services. The GCC is building research capacity through academic medical cities, precision medicine programs, radiopharmaceutical interest, and sovereign investment in healthcare innovation, creating opportunities for advanced imaging platforms that support oncology, metabolic disease, neurology, and translational research.

The European Union provides a mature environment for collaborative imaging science, data governance, animal welfare standards, and translational research networks that favor standardized protocols and interoperable analytics. BRICS economies contribute scale, expanding drug discovery capacity, and increasing domestic innovation across pharmaceuticals, biotechnology, and imaging instrumentation, while G7 markets remain central to premium system adoption, regulatory science, radiotracer research, and pharmaceutical R&D. NATO-aligned markets benefit from strong university, public-sector, and defense-adjacent biomedical research ecosystems, particularly in trauma, infectious disease, radiation biology, biodefense, and advanced diagnostics.

Key Country Insights for Preclinical Imaging Adoption

The United States leads in installed research infrastructure, biotechnology financing, CRO specialization, molecular imaging innovation, and federally supported biomedical science, while Canada contributes strong academic imaging centers and established neuroscience, oncology, and radiotracer research programs. Mexico and Brazil are strengthening regional access through public research institutes, university-based biomedical programs, and pharmaceutical partnerships, and the United Kingdom remains influential in translational imaging, radiochemistry, animal model research, and contract research services.

Germany, France, Italy, and Spain support Europe’s preclinical imaging base through medical technology expertise, academic consortia, nuclear medicine capabilities, and pharmaceutical R&D, while Russia retains capabilities in nuclear medicine, radiophysics, and basic biomedical research despite geopolitical constraints. China is scaling rapidly across drug discovery, biotechnology, imaging instrumentation, and academic research infrastructure; India is expanding cost-efficient CRO and academic research capacity; Japan remains strong in precision instrumentation, imaging physics, and radiotracer science; Australia offers high-quality translational research networks and comparative medicine expertise; and South Korea is advancing biotechnology, oncology, digital imaging workflows, and radiopharmaceutical research.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize multimodal platforms, validated quantitative biomarkers, standardized imaging protocols, and interoperable data systems that connect preclinical findings with clinical trial endpoints. Technology providers can improve competitiveness by offering modular systems, AI-assisted analytics, application-specific probes, remote service models, and training programs that reduce technical barriers for academic, pharmaceutical, biotechnology, and CRO users.

Pharma, biotech, and CRO decision-makers should align imaging endpoints with mechanism-of-action hypotheses early in study design and build quality controls for acquisition, reconstruction, analysis, and reporting. Strategic partnerships with radiochemistry laboratories, AI software developers, animal model specialists, imaging core facilities, and regulatory consultants can shorten study timelines while strengthening confidence in translational evidence.

Research Methodology

This executive summary is developed using a structured secondary-research approach that emphasizes verified public sources, regulatory guidance, peer-reviewed biomedical literature, funding program information, patent and product documentation, and recognized industry signals across drug discovery, imaging instrumentation, radiopharmaceutical development, and translational research. The methodology focuses on triangulating technology adoption, end-user demand, regional research capacity, and competitive positioning without relying on market sizing, market share, or forecasting claims.

Interpretation is based on qualitative and directional evidence rather than unsupported assumptions. Insights are validated through cross-comparison of scientific use cases, regulatory expectations for data integrity, documented advances in imaging modalities, and observable investment patterns in pharmaceutical R&D, CRO services, AI-enabled analytics, radiochemistry, molecular probes, and academic translational infrastructure.

Conclusion

Preclinical imaging is evolving from a specialized research tool into a strategic translational platform that improves decision-making across drug discovery and development. The most compelling opportunities are linked to multimodal imaging, AI-enabled quantification, targeted probes, radiopharmaceutical innovation, and outsourced imaging services that help sponsors produce reproducible and clinically relevant evidence.

Organizations that combine scientific validation, workflow integration, data integrity, and regional partnership strategies will be best positioned to capture value. As precision medicine, biologics, cell and gene therapies, and molecular diagnostics advance, preclinical imaging will remain essential for connecting biological mechanism, therapeutic response, and translational confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Preclinical Imaging Market, by Product
7.1. Reagents
7.1.1. Bioluminescent Imaging Reagents
7.1.2. Fluorescent Imaging Reagents
7.1.3. MRI Contrasting Reagents
7.1.4. PET Radioactive Tracers
7.1.5. Ultrasound Contrasting Reagents
7.1.6. X-ray CT Contrasting Reagents
7.2. Software & Services
8. Preclinical Imaging Market, by Type
8.1. Multimodal Systems
8.2. Standalone Imaging Systems
9. Preclinical Imaging Market, by Imaging Modality
9.1. Magnetic Particle Imaging
9.2. Magnetic Resonance Imaging
9.3. Micro-Computed Tomography
9.4. Optical Imaging
9.5. Positron Emission Tomography
9.6. Single-Photon Emission Computed Tomography
10. Preclinical Imaging Market, by Applications
10.1. Cardiology
10.2. Drug Development
10.3. Immunology & Inflammation
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
11. Preclinical Imaging Market, by End Users
11.1. Academic & Research Institutes
11.2. Contract Research Organizations
11.3. Pharmaceutical & Biotechnology Companies
12. Asia-Pacific Preclinical Imaging Market
13. Europe Preclinical Imaging Market
14. North America Preclinical Imaging Market
15. Latin America Preclinical Imaging Market
16. Africa Preclinical Imaging Market
17. Middle East Preclinical Imaging Market
18. NATO Preclinical Imaging Market
19. G7 Preclinical Imaging Market
20. BRICS Preclinical Imaging Market
21. European Union Preclinical Imaging Market
22. ASEAN Preclinical Imaging Market
23. GCC Preclinical Imaging Market
24. China Preclinical Imaging Market
25. United States Preclinical Imaging Market
26. Japan Preclinical Imaging Market
27. India Preclinical Imaging Market
28. Germany Preclinical Imaging Market
29. United Kingdom Preclinical Imaging Market
30. Australia Preclinical Imaging Market
31. France Preclinical Imaging Market
32. South Korea Preclinical Imaging Market
33. Italy Preclinical Imaging Market
34. Canada Preclinical Imaging Market
35. Russia Preclinical Imaging Market
36. Brazil Preclinical Imaging Market
37. Mexico Preclinical Imaging Market
38. Spain Preclinical Imaging Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Advanced Molecular Vision, Inc.
40.2. Agilent Technologies, Inc.
40.3. Angstrom Advanced Inc.
40.4. Aspect Imaging Ltd.
40.5. AXT Pty Ltd
40.6. Berthold Technologies
40.7. Bruker Corporation
40.8. Cubresa, Inc.
40.9. Euro-BioImaging ERIC
40.10. FUJIFILM Holdings America Corporation
40.11. GE HealthCare Technologies Inc.
40.12. IVIM Technology Corp.
40.13. KUB Technologies, Inc.
40.14. LI-COR, Inc.
40.15. Mediso Ltd.
40.16. Milabs B.V.
40.17. Miltenyi Biotec GmbH
40.18. MR Solutions Ltd.
40.19. PerkinElmer Inc.
40.20. Revvity, Inc.
40.21. Scitech Pty Ltd
40.22. Siemens AG
40.23. TriFoil Imaging
40.24. United Imaging Healthcare Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PRECLINICAL IMAGING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PRECLINICAL IMAGING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PRECLINICAL IMAGING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PRECLINICAL IMAGING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. NATO PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. NATO PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. G7 PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. G7 PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. GCC PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. GCC PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. CHINA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. JAPAN PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. INDIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. FRANCE PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CANADA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. RUSSIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. BRAZIL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. MEXICO PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SPAIN PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOLUMINESCENT IMAGING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENT IMAGING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MRI CONTRASTING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MRI CONTRASTING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MRI CONTRASTING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PET RADIOACTIVE TRACERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PET RADIOACTIVE TRACERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PET RADIOACTIVE TRACERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ULTRASOUND CONTRASTING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ULTRASOUND CONTRASTING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ULTRASOUND CONTRASTING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL X-RAY CT CONTRASTING REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL X-RAY CT CONTRASTING REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL X-RAY CT CONTRASTING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MULTIMODAL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MULTIMODAL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MULTIMODAL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL STANDALONE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STANDALONE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STANDALONE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MAGNETIC PARTICLE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MAGNETIC PARTICLE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MAGNETIC PARTICLE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MICRO-COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MICRO-COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MICRO-COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OPTICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNOLOGY & INFLAMMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 95. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 98. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 116. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 118. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 119. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 120. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 121. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 130. NATO PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. NATO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 132. NATO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 133. NATO PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 134. NATO PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 135. NATO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 136. NATO PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 137. G7 PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. G7 PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139. G7 PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 140. G7 PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 141. G7 PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 142. G7 PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 143. G7 PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 144. BRICS PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. BRICS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. BRICS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. BRICS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148. BRICS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 149. BRICS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 150. BRICS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 158. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 160. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 161. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 165. GCC PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GCC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 167. GCC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 168. GCC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 169. GCC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 170. GCC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 171. GCC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 172. CHINA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 174. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. CHINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 176. CHINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 177. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 178. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 186. JAPAN PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 187. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 188. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 189. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 190. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 191. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 192. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 193. INDIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 195. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 196. INDIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 197. INDIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 198. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 199. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 200. GERMANY PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 201. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 202. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 203. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 204. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 205. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 206. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 207. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 208. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 209. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 210. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 211. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 212. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 213. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 214. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 216. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 217. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 218. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 219. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 220. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 221. FRANCE PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 222. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 223. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 224. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 225. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 226. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 227. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 228. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 229. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 230. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 231. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 232. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 233. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 234. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 235. ITALY PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 237. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 238. ITALY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 239. ITALY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 240. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 241. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 242. CANADA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 244. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 245. CANADA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 246. CANADA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 247. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 248. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 249. RUSSIA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 250. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 251. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 252. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 253. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 254. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 255. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 256. BRAZIL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 259. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 260. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 261. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 262. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 263. MEXICO PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 264. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 265. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 266. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 267. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 268. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 269. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 270. SPAIN PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 271. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 272. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 273. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 274. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 275. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 276. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Preclinical Imaging market report include:
  • Advanced Molecular Vision, Inc.
  • Agilent Technologies, Inc.
  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • AXT Pty Ltd
  • Berthold Technologies
  • Bruker Corporation
  • Cubresa, Inc.
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings America Corporation
  • GE HealthCare Technologies Inc.
  • IVIM Technology Corp.
  • KUB Technologies, Inc.
  • LI-COR, Inc.
  • Mediso Ltd.
  • Milabs B.V.
  • Miltenyi Biotec GmbH
  • MR Solutions Ltd.
  • PerkinElmer Inc.
  • Revvity, Inc.
  • Scitech Pty Ltd
  • Siemens AG
  • TriFoil Imaging
  • United Imaging Healthcare Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.81 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Optical Preclinical Imaging Market by Technology, Product Type, Application, End User - Global Forecast 2026-2032 - Product Image

Optical Preclinical Imaging Market by Technology, Product Type, Application, End User - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends Analysis Report by Type, Application, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Preclinical Imaging Market Size, Share & Trends Analysis Report by Type, Application, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Preclinical Imaging Market Report 2026 - Product Image

Preclinical Imaging Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Optical Preclinical Imaging - Global Strategic Business Report - Product Image

Optical Preclinical Imaging - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From

About the Preclinical Imaging Market

The Preclinical Imaging market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Preclinical Imaging is the use of imaging technologies to study the effects of drugs on living organisms. This includes techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET). These technologies allow researchers to observe the effects of drugs on the body in real-time, providing valuable insights into the efficacy and safety of potential treatments. Preclinical Imaging is used to assess the safety and efficacy of drugs before they are tested in clinical trials. Some companies in the Preclinical Imaging market include Bruker, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, and GE Healthcare. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.